Gyrolab users regard this system as a must-have technology for accelerating biopharmaceutical development and production.
Speed of assay development, small samples and reagent volumes, as well as the ability to measure concentrations over a broad dynamic range with minimal matrix interference are key attributes for time-critical workflows.
The open Gyrolab platform is constantly expanding. As well as ever more advanced instrumentation and software, the range of optimised, ready-to-use kits for cell line development, bioprocessing applications and pre-clinical pharmacokinetic (PK) / toxicokinetic (TK) continues to grow.
Download to find out more.